Mitsubishi UFJ Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $192K | Buy |
37,853
+6,989
| +23% | +$35.4K | ﹤0.01% | 981 |
|
|
2025
Q1 | $163K | Buy |
30,864
+2,587
| +9% | +$13.7K | ﹤0.01% | 977 |
|
|
2024
Q4 | $221K | Buy |
28,277
+7,902
| +39% | +$61.6K | ﹤0.01% | 976 |
|
|
2024
Q3 | $134K | Sell |
20,375
-1,917
| -9% | -$12.6K | ﹤0.01% | 1002 |
|
|
2024
Q2 | $167K | Sell |
22,292
-2,622
| -11% | -$19.7K | ﹤0.01% | 981 |
|
|
2024
Q1 | $248K | Sell |
24,914
-1,141
| -4% | -$11.4K | ﹤0.01% | 937 |
|
|
2023
Q4 | $252K | Sell |
26,055
-6,947
| -21% | -$67.3K | ﹤0.01% | 987 |
|
|
2023
Q3 | $252K | Buy |
33,002
+1,938
| +6% | +$14.8K | ﹤0.01% | 1001 |
|
|
2023
Q2 | $232K | Buy |
31,064
+10,285
| +49% | +$76.8K | ﹤0.01% | 1022 |
|
|
2023
Q1 | $139K | Buy |
20,779
+2,046
| +11% | +$13.6K | ﹤0.01% | 1065 |
|
|
2022
Q4 | $141K | Buy |
+18,733
| New | +$141K | ﹤0.01% | 1058 |
|
|
2022
Q2 | – | Sell |
-16,347
| Closed | -$117K | – | 1194 |
|
|
2022
Q1 | $117K | Buy |
16,347
+1,390
| +9% | +$9.95K | ﹤0.01% | 1116 |
|
|
2021
Q4 | $270K | Buy |
+14,957
| New | +$270K | ﹤0.01% | 1033 |
|